Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2), has become an ongoing pandemic worldwide. However, there are no vaccines or antiviral drugs with proven clinical efficacy. Therefore, a remedial measure is urgently needed to combat the devastating COVID-19. The pharmacological activities of N-acetylcysteine (NAC) and its potential functions in inhibiting the progression of COVID-19 make it a promising therapeutic agent for the infection. In this mini-review, we discussed the therapeutic potential of NAC in COVID-19 from the perspective of its multisite pharmacological actions.
第一作者单位：[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pharm, Wuhan 430030, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Luo Pan,Liu Yi,Liu Dong,et al.Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19[J].MINI-REVIEWS IN MEDICINAL CHEMISTRY.2021,21(3):268-272.doi:10.2174/1389557520666201027160833.
APA：
Luo, Pan,Liu, Yi,Liu, Dong&Li, Juan.(2021).Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19.MINI-REVIEWS IN MEDICINAL CHEMISTRY,21,(3)
MLA：
Luo, Pan,et al."Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19".MINI-REVIEWS IN MEDICINAL CHEMISTRY 21..3(2021):268-272
：